CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Clinical trials for CHRONIC OBSTRUCTIVE PULMONARY DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC OBSTRUCTIVE PULMONARY DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended safety check for COPD-related heart-lung drug
Disease control TerminatedThis study aimed to check the long-term safety of an inhaled medication called treprostinil for people with both chronic obstructive pulmonary disease (COPD) and high blood pressure in their lungs. It was an extension study for 41 participants who had already completed a previous…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Major trial tests new inhaler to tame COPD Flare-Ups
Disease control TerminatedThis study tested a new inhaled medication, CHF6001 (Tanimilast), as an add-on treatment for adults with severe COPD and chronic bronchitis. Over 3,900 participants, who were already on standard triple therapy, received the new drug or a placebo for one year. The main goal was to…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Early trial for Mucus-Busting lung drug halted
Disease control TerminatedThis early-stage study tested an inhaled drug called ARO-MUC5AC, designed to reduce harmful mucus in the lungs. It aimed to see if the drug was safe and how it worked in healthy volunteers and people with moderate-to-severe asthma or COPD. The study was terminated, meaning it was…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Major trial tests new inhaler to tame COPD Flare-Ups
Disease control TerminatedThis large, year-long study tested whether adding a new inhaled drug called CHF6001 to standard triple therapy could better control COPD in people with chronic bronchitis. It aimed to see if the add-on treatment could reduce the number of serious breathing flare-ups and improve l…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New inhaler tested to help COPD patients breathe easier
Disease control TerminatedThis study tested a new inhaled medication, HRG2005, for people with moderate to severe chronic obstructive pulmonary disease (COPD). It aimed to see if the treatment could improve lung function and reduce the frequency of serious symptom flare-ups over nearly a year. The study w…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Gut bugs for lungs and blood sugar? small trial tests probiotic idea
Disease control TerminatedThis small study tested whether taking probiotic supplements for 12 weeks could help people who have both type 2 diabetes and COPD. Researchers wanted to see if the probiotics could lower blood sugar levels and improve breathing. The study was terminated early and only involved 3…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Glac Biotech Co., Ltd • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Doctors test 'Smart Stethoscope' to listen for lung disease clues
Diagnosis TerminatedThis study tested whether a special electronic stethoscope and artificial intelligence (AI) could help doctors better detect and measure abnormal lung sounds. It involved 23 adults with cystic fibrosis, pulmonary fibrosis, or COPD. The goal was to see if this technology could bec…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Diagnosis
Last updated Mar 23, 2026 15:17 UTC
-
Home comfort care tested to ease suffering for seriously ill
Symptom relief TerminatedThis study aimed to see if bringing specialized comfort care (palliative care) into patients' homes could improve their well-being and reduce hospital visits. It focused on adults with serious conditions like cancer, heart failure, or COPD who were not in hospice. The trial compa…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
COPD patients: can rehab at home work as well as at a clinic?
Symptom relief TerminatedThis study aimed to see if a breathing and exercise program done at home is as effective as the same program done at a medical center for people with COPD. It involved 188 adults with moderate to severe COPD and measured their exercise ability, breathlessness, and quality of life…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Mar 24, 2026 12:01 UTC